BioStem Life Sciences, a wholly owned subsidiary of BioStem Technologies, Inc. today announced the buildout of a brand new R&D lab. Situated in the Company’s 6,100 sq. Ft., state-of-the-art, FDA registered, cGMP facility, this new lab will support the research and development
March 13, 2020
· 3 min read